{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:40:33Z","timestamp":1790638833628,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12896-019-0527-5","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T08:02:43Z","timestamp":1559894563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Investigation of cell culture conditions for optimal foot-and-mouth disease virus production"],"prefix":"10.1186","volume":"19","author":[{"given":"Veronika","family":"Dill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-0695","authenticated-orcid":false,"given":"Michael","family":"Eschbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"issue":"3","key":"527_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.20506\/rst.21.3.1353","volume":"21","author":"D Thompson","year":"2002","unstructured":"Thompson D, Muriel P, Russell D, Osborne P, Bromley A, Rowland M, et al. Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev Sci Tech. 2002;21(3):675\u201387.","journal-title":"Rev Sci Tech"},{"issue":"41","key":"527_CR2","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1016\/j.vaccine.2011.05.078","volume":"29","author":"MA Spitteler","year":"2011","unstructured":"Spitteler MA, Fernandez I, Schabes E, Krimer A, Regulier EG, Guinzburg M, et al. Foot and mouth disease (FMD) virus: quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography. Vaccine. 2011;29(41):7182\u20137.","journal-title":"Vaccine."},{"issue":"1","key":"527_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","volume":"91","author":"TR Doel","year":"2003","unstructured":"Doel TR. FMD vaccines. Virus Res. 2003;91(1):81\u201399.","journal-title":"Virus Res"},{"issue":"2","key":"527_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/0042-6822(58)90102-8","volume":"6","author":"JE Darnell Jr","year":"1958","unstructured":"Darnell JE Jr, Eagle H. Glucose and glutamine in poliovirus production by HeLa cells. Virology. 1958;6(2):556\u201366.","journal-title":"Virology."},{"issue":"2","key":"527_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.104.2.271","volume":"104","author":"H Eagle","year":"1956","unstructured":"Eagle H, Habel K. The nutritional requirements for the propagation of poliomyelitis virus by the HeLa cell. J Exp Med. 1956;104(2):271\u201387.","journal-title":"J Exp Med"},{"issue":"2","key":"527_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/(SICI)1097-0290(1999)66:2<104::AID-BIT3>3.0.CO;2-#","volume":"66","author":"HJ Cruz","year":"1999","unstructured":"Cruz HJ, Moreira JL, Carrondo MJ. Metabolic shifts by nutrient manipulation in continuous cultures of BHK cells. Biotechnol Bioeng. 1999;66(2):104\u201313.","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"527_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0300-9084(92)90016-8","volume":"74","author":"LG Baggetto","year":"1992","unstructured":"Baggetto LG. Deviant energetic metabolism of glycolytic cancer cells. Biochimie. 1992;74(11):959\u201374.","journal-title":"Biochimie."},{"issue":"2","key":"527_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/infdis\/100.2.109","volume":"100","author":"HB Levy","year":"1957","unstructured":"Levy HB, Baron S. The effect of animal viruses on host cell metabolism. II. Effect of poliomyelitis virus on glycolysis and uptake of glycine by monkey kidney tissue cultures. J Infect Dis. 1957;100(2):109\u201318.","journal-title":"J Infect Dis"},{"issue":"5","key":"527_CR9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/IAI.9.5.824-827.1974","volume":"9","author":"D Bardell","year":"1974","unstructured":"Bardell D, Essex M. Glycolysis during early infection of feline and human cells with feline leukemia virus. Infect Immun. 1974;9(5):824\u20137.","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"527_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF01310541","volume":"87","author":"MA Gray","year":"1986","unstructured":"Gray MA, James MH, Booth JC, Pasternak CA. Increased sugar transport in BHK cells infected with Semliki Forest virus or with herpes simplex virus. Arch Virol. 1986;87(1\u20132):37\u201348.","journal-title":"Arch Virol"},{"issue":"8","key":"527_CR11","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1128\/JVI.03134-13","volume":"88","author":"KA Fontaine","year":"2014","unstructured":"Fontaine KA, Camarda R, Lagunoff M. Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol. 2014;88(8):4366\u201374.","journal-title":"J Virol"},{"issue":"12","key":"527_CR12","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1371\/journal.ppat.0020132","volume":"2","author":"J Munger","year":"2006","unstructured":"Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006;2(12):e132.","journal-title":"PLoS Pathog"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.virol.2015.02.038","volume":"479\u2013480","author":"EL Sanchez","year":"2015","unstructured":"Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015;479\u2013480:609\u201318.","journal-title":"Virology."},{"issue":"7","key":"527_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/biot.201000080","volume":"5","author":"ND Maynard","year":"2010","unstructured":"Maynard ND, Gutschow MV, Birch EW, Covert MW. The virus as metabolic engineer. Biotechnol J. 2010;5(7):686\u201394.","journal-title":"Biotechnol J"},{"key":"527_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/JB.83.3.579-583.1962","volume":"83","author":"RA Pledger","year":"1962","unstructured":"Pledger RA, Polatnick J. Defined medium for growth of foot-and-mouth disease virus. J Bacteriol. 1962;83:579\u201383.","journal-title":"J Bacteriol"},{"issue":"24","key":"527_CR16","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.vaccine.2014.02.022","volume":"32","author":"YE Thomassen","year":"2014","unstructured":"Thomassen YE, Rubingh O, Wijffels RH, van der Pol LA, Bakker WA. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods. Vaccine. 2014;32(24):2782\u20138.","journal-title":"Vaccine."},{"issue":"16","key":"527_CR17","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1016\/j.vaccine.2006.01.019","volume":"24","author":"Y Genzel","year":"2006","unstructured":"Genzel Y, Fischer M, Reichl U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine. 2006;24(16):3261\u201372.","journal-title":"Vaccine."},{"issue":"2","key":"527_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","volume":"17","author":"MJ Grubman","year":"2004","unstructured":"Grubman MJ, Baxt B. Foot-and-mouth disease. Clin Microbiol Rev. 2004;17(2):465\u201393.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"527_CR19","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1128\/JVI.03358-14","volume":"89","author":"F Caridi","year":"2015","unstructured":"Caridi F, Vazquez-Calvo A, Sobrino F, Martin-Acebes MA. The pH stability of foot-and-mouth disease virus particles is modulated by residues located at the Pentameric Interface and in the N terminus of VP1. J Virol. 2015;89(10):5633\u201342.","journal-title":"J Virol"},{"issue":"1","key":"527_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.virol.2007.07.021","volume":"369","author":"MA Martin-Acebes","year":"2007","unstructured":"Martin-Acebes MA, Gonzalez-Magaldi M, Sandvig K, Sobrino F, Armas-Portela R. Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol. Virology. 2007;369(1):105\u201318.","journal-title":"Virology."},{"issue":"2","key":"527_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0042-6822(84)90208-3","volume":"135","author":"EC Carrillo","year":"1984","unstructured":"Carrillo EC, Giachetti C, Campos RH. Effect of lysosomotropic agents on the foot-and-mouth disease virus replication. Virology. 1984;135(2):542\u20135.","journal-title":"Virology."},{"issue":"6","key":"527_CR22","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1128\/JVI.02311-09","volume":"84","author":"MA Martin-Acebes","year":"2010","unstructured":"Martin-Acebes MA, Rincon V, Armas-Portela R, Mateu MG, Sobrino F. A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition. J Virol. 2010;84(6):2902\u201312.","journal-title":"J Virol"},{"issue":"3","key":"527_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0168-1702(87)90032-3","volume":"7","author":"B Baxt","year":"1987","unstructured":"Baxt B. Effect of lysosomotropic compounds on early events in foot-and-mouth disease virus replication. Virus Res. 1987;7(3):257\u201371.","journal-title":"Virus Res"},{"issue":"17\u201318","key":"527_CR24","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.vaccine.2003.11.041","volume":"22","author":"Y Genzel","year":"2004","unstructured":"Genzel Y, Behrendt I, Konig S, Sann H, Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine. 2004;22(17\u201318):2202\u20138.","journal-title":"Vaccine."},{"issue":"Suppl 1","key":"527_CR25","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1002\/jgm.503","volume":"6","author":"A Kamen","year":"2004","unstructured":"Kamen A, Henry O. Development and optimization of an adenovirus production process. J Gene Med. 2004;6(Suppl 1):S184\u201392.","journal-title":"J Gene Med"},{"issue":"2","key":"527_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0042-6822(82)90085-X","volume":"119","author":"HA Wood","year":"1982","unstructured":"Wood HA, Johnston LB, Burand JP. Inhibition of Autographa californica nuclear polyhedrosis virus replication in high-density Trichoplusia ni cell cultures. Virology. 1982;119(2):245\u201354.","journal-title":"Virology."},{"issue":"1","key":"527_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF02922022","volume":"30","author":"T Hassell","year":"1991","unstructured":"Hassell T, Gleave S, Butler M. Growth inhibition in animal cell culture. The effect of lactate and ammonia. Appl Biochem Biotechnol. 1991;30(1):29\u201341.","journal-title":"Appl Biochem Biotechnol"},{"key":"527_CR28","volume-title":"Minimum biorisk management standards for laboratories working with foot-and-mouth disease virus Italy","author":"European Commision for the Control of Foot-and-Mouth Disease","year":"2013","unstructured":"European Commision for the Control of Foot-and-Mouth Disease. Minimum biorisk management standards for laboratories working with foot-and-mouth disease virus Italy 2013 Available from: \n                    http:\/\/www.fao.org\/fileadmin\/user_upload\/eufmd\/Lab_guidelines\/FMD_Minimumstandards_2013_Final_version.pdf\n                    \n                  ."},{"key":"527_CR29","first-page":"227","volume":"2","author":"C Spearman","year":"1908","unstructured":"Spearman C. The method of \u201cright and wrong cases\u201d (constant stimuli) without Gauss\u2019s formula. Br J Psychol. 1908;2:227\u201342.","journal-title":"Br J Psychol"},{"key":"527_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Archiv f experiment Pathol u Pharmakol. 1931;162:480\u20133.","journal-title":"Archiv f experiment Pathol u Pharmakol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-019-0527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-019-0527-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-019-0527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T19:11:19Z","timestamp":1591384279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-019-0527-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s12896-019-0527-5","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB and ME declare that they have no competing interests. VD\u2019s position was funded by the project. AZ is an employee of Merck Life Science.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}